Ceralifimod
Ceralifimod Uses, Dosage, Side Effects, Food Interaction and all others data.
Ceralifimod is under investigation in clinical trial NCT01226745 (Phase 2 Extension Trial in Patients With Relapsing-remitting Multiple Sclerosis (RRMS)).
Trade Name | Ceralifimod |
Generic | Ceralifimod |
Ceralifimod Other Names | Ceralifimod |
Type | |
Formula | C27H33NO4 |
Weight | Average: 435.564 Monoisotopic: 435.240958547 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Ceralifimod